Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -9.66% is 232% below its 5-year average of 7.30%, around the middle of its 5-year range (-70.63%–22.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 412.02% below its 12-month average of 3.10%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
-9.66%
EBITDA MARGIN AVG TTM
3.10%
EBITDA MARGIN AVG 3Y
13.42%
EBITDA MARGIN AVG 5Y
15.12%
EBITDA MARGIN AVG 10Y
17.80%
EBITDA MARGIN AVG 15Y
18.83%
EBITDA MARGIN AVG 20Y
20.42%
CURRENT VS TTM AVG
-412.02%
CURRENT VS 3Y AVG
-171.99%
CURRENT VS 5Y AVG
-163.91%
CURRENT VS 10Y AVG
-154.29%
CURRENT VS 15Y AVG
-151.31%
CURRENT VS 20Y AVG
-147.32%
Baxter International Inc.
Market Cap
$13.51B
EBITDA Margin
-9.66%
TTM Avg
3.10%
3Y Avg
13.42%
5Y Avg
15.12%
Market Cap
$14.10B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$14.80B
EBITDA Margin
32.07%
TTM Avg
25.68%
3Y Avg
26.69%
5Y Avg
27.49%
Market Cap
$12.11B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$11.29B
EBITDA Margin
17.40%
TTM Avg
22.43%
3Y Avg
29.14%
5Y Avg
30.66%
Market Cap
$11.20B
EBITDA Margin
22.69%
TTM Avg
18.62%
3Y Avg
20.95%
5Y Avg
21.80%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baxter International Inc. (BAX) | $13.51B | -9.66% | 3.10% | 13.42% | 15.12% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 27.02% | 27.38% | 26.41% | 26.36% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 23.07% | 26.75% | 30.05% | 32.80% |
| Solventum Corporation (SOLV)vs › | $14.80B | 32.07% | 25.68% | 26.69% | 27.49% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 19.75% | 19.29% | 19.87% | 21.06% |
| DaVita Inc. (DVA)vs › | $15.41B | 19.98% | 20.97% | 19.78% | 20.10% |
| Insulet Corp. (PODD)vs › | $11.45B | 21.67% | 20.24% | 16.36% | 15.66% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 17.40% | 22.43% | 29.14% | 30.66% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | 22.69% | 18.62% | 20.95% | 21.80% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.11B | 22.25% | 22.41% | 21.18% | 20.68% |
Gross Margin
30.1%
EBITDA Margin
-9.7%
Operating Margin
-4.7%
Net Margin
-9.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -9.66% |
| 2026-03-31 | 11.22% |
| 2025-12-31 | -16.44% |
| 2025-09-30 | 14.43% |
| 2025-06-30 | 15.94% |
| 2025-03-31 | 11.62% |
| 2024-12-31 | -6.90% |
| 2024-09-30 | 15.15% |
| 2024-06-30 | 15.07% |
| 2024-03-31 | 15.50% |
| 2023-12-31 | 16.81% |
| 2023-09-30 | 10.43% |
| 2023-06-30 | 8.04% |
| 2023-03-31 | 12.58% |
| 2022-12-31 | 17.67% |
| 2022-09-30 | -70.63% |
| 2022-06-30 | 16.89% |
| 2022-03-31 | 14.65% |
| 2021-12-31 | 17.87% |
| 2021-09-30 | 22.29% |
| 2021-06-30 | 20.85% |
| 2021-03-31 | 20.60% |
| 2020-12-31 | 19.46% |
| 2020-09-30 | 22.85% |
| 2020-06-30 | 19.61% |
| 2020-03-31 | 21.70% |
| 2019-12-31 | 24.51% |
| 2019-09-30 | 24.48% |
| 2019-06-30 | 19.16% |
| 2019-03-31 | 21.80% |
| 2018-12-31 | 20.73% |
| 2018-09-30 | 21.04% |
| 2018-06-30 | 20.37% |
| 2018-03-31 | 23.31% |
| 2017-12-31 | 17.38% |
| 2017-09-30 | 17.88% |
| 2017-06-30 | 20.38% |
| 2017-03-31 | 22.10% |
| 2016-12-31 | 18.26% |
| 2016-09-30 | 15.25% |
| 2016-06-30 | 10.60% |
| 2016-03-31 | 15.87% |
| 2015-12-31 | 13.22% |
| 2015-09-30 | 12.38% |
| 2015-06-30 | 11.19% |
| 2015-03-31 | 11.61% |
| 2014-12-31 | 23.61% |
| 2014-09-30 | 11.81% |
| 2014-06-30 | 21.95% |
| 2014-03-31 | 23.60% |
| 2013-12-31 | 16.09% |
| 2013-09-30 | 23.21% |
| 2013-06-30 | 27.56% |
| 2013-03-31 | 26.04% |
| 2012-12-31 | 20.04% |
| 2012-09-30 | 27.49% |
| 2012-06-30 | 26.79% |
| 2012-03-31 | 25.62% |
| 2011-12-31 | 22.04% |
| 2011-09-30 | 26.47% |
| 2011-06-30 | 28.28% |
| 2011-03-31 | 27.50% |
| 2010-12-31 | 20.07% |
| 2010-09-30 | 29.56% |
| 2010-06-30 | 27.14% |
| 2010-03-31 | 10.22% |
| 2009-12-31 | 26.08% |
| 2009-09-30 | 28.49% |
| 2009-06-30 | 28.85% |
| 2009-03-31 | 28.79% |
| 2008-12-31 | 27.21% |
| 2008-09-30 | 24.60% |
| 2008-06-30 | 27.03% |
| 2008-03-31 | 24.54% |
| 2007-12-31 | 25.36% |
| 2007-09-30 | 23.67% |
| 2007-06-30 | 23.72% |
| 2007-03-31 | 24.82% |
| 2006-12-31 | 24.10% |
| 2006-09-30 | 25.42% |
| 2006-06-30 | 21.63% |
| 2006-03-31 | 21.88% |
| 2005-12-31 | 19.71% |
| 2005-09-30 | 22.14% |
| 2005-06-30 | 26.85% |
| 2005-03-31 | 19.97% |
| 2004-12-31 | 13.80% |
| 2004-09-30 | 22.72% |
| 2004-06-30 | -4.96% |
| 2004-03-31 | 19.87% |
| 2003-12-31 | 26.17% |
| 2003-09-30 | 24.20% |
| 2003-06-30 | 7.40% |
| 2003-03-31 | 22.98% |
| 2002-12-31 | 23.58% |
| 2002-09-30 | 26.59% |
